CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD

    CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…

    April 18, 2022| Arthur N. Brodsky, PhD
  • Mining the Mysteries of Myeloid Cells with CRI Lloyd J. Old STAR Malay Haldar

    CRI Lloyd J. Old STAR Malay Haldar is exploring the role of dendritic cells and macrophages in…

    March 28, 2022| Arthur N. Brodsky, PhD
  • Neutrophils and Inflammation in Colorectal Cancer with CRI Lloyd J. Old STAR Ivan Zanoni

    CRI Lloyd J. Old STAR Ivan Zanoni is exploring the multifaceted roles of neutrophils in colorectal cancer.

    March 21, 2022| Arthur N. Brodsky, PhD
  • Overcoming Immune Dysfunction in Brain Cancer with CRI Lloyd J. Old STAR Peter Fecci

    CRI Arash Ferdowsi Lloyd J. Old STAR Peter Fecci is seeking to characterize and develop ways to…

    February 14, 2022| Arthur N. Brodsky, PhD
  • CRI Scientist’s “Rosetta Stone” Tech Unlocks New Era

    Dr. Alex Marson, a CRI-funded STAR, has developed a new genetic screening technology with potential to significantly…

    February 10, 2022| Jill O'Donnell-Tormey, PhD
  • Engineering Bacteria to Improve Cancer Immunotherapy with CRI Lloyd J. Old STAR Tal Danino

    CRI Lloyd J. Old STAR Tal Danino is exploring how to engineer bacteria to help our bodies…

    January 24, 2022| Arthur N. Brodsky, PhD
  • Improving Cell Therapies by Characterizing Our Immune Arsenal with CRI STAR Dr. Ning Jenny Jiang

    Dr. Ning Jenny Jiang, a CRI Lloyd J. Old STAR at the University of Pennsylvania, is working to…

    November 30, 2021| Arthur N. Brodsky, PhD
  • Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer

    CRI highlights some of the many women who are and have been integral to our organization and…

    March 24, 2021| Arthur N. Brodsky, PhD
  • Fuel for the Fight: How Cancer Metabolism Impacts the Immune System, with Dr. Greg Delgoffe

    CRI Lloyd J. Old STAR Greg Delgoffe is exploring how cancer metabolism impacts the immune system and…

    March 3, 2021| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute